Needham & Company Maintains a 'Hold' on Valence Technology (VLNC); Quotation Activity Increased, But Outlook Bit Weaker
Get Alerts VLNC Hot Sheet
Price: $0.65 --0%
Rating Summary:
0 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Rating Summary:
0 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Join SI Premium – FREE
Needham & Company maintains a 'Hold' on Valence Technology (NASDAQ: VLNC).
Analyst, Michael Lew, said, "Although the outlook was a bit weaker than anticipated, Valence Technology’s quotation activity is increasing due to the combination of new market opportunities (such as lead acid replacement) and potential customer takeaways from A123 Systems (Nasdaq: AONE). However, an incremental sales boost has not been recognized yet and is still to be determined. We are maintaining our neutral stance on VLNC shares until financial visibility improves." (Needham adjusts FY13 loss from $0.03 to $0.05)
For an analyst ratings summary and ratings history on Valence Technology click here. For more ratings news on Valence Technology click here.
Shares of Valence Technology closed at $0.67 yesterday.
Analyst, Michael Lew, said, "Although the outlook was a bit weaker than anticipated, Valence Technology’s quotation activity is increasing due to the combination of new market opportunities (such as lead acid replacement) and potential customer takeaways from A123 Systems (Nasdaq: AONE). However, an incremental sales boost has not been recognized yet and is still to be determined. We are maintaining our neutral stance on VLNC shares until financial visibility improves." (Needham adjusts FY13 loss from $0.03 to $0.05)
For an analyst ratings summary and ratings history on Valence Technology click here. For more ratings news on Valence Technology click here.
Shares of Valence Technology closed at $0.67 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nexxen (NEXN) PT Raised to $13 at Needham
- Draganfly Inc. (DPRO) PT Lowered to $8 at Needham
- Monopar Therapeutics (MNPR) PT Raised to $133 at BTIG
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
Needham & CompanySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share